BEST OF ONCOLOGY WEST 2024: Lymphoma Update – Dr. Kerry Savage
OR
Chair
Dr. Sharlene Gill
Dr. Daniel Heng
Panelist
Dr. Kerry Savage
Studies/trials discussed:
- Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors
- 302 Efficacy and Safety of Valemetostat Monotherapy in Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results of the Phase 2 VALENTINE-PTCL01 Study
- The outcome of older adults with classic Hodgkin lymphoma in British Columbia
- Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study
